Omnichem

Ajinomoto Bio-Pharma Services, formerly known as Omnichem, is a leading global contract development and manufacturing organization (CDMO) that provides a wide range of services to the pharmaceutical and biotechnology industries. The company specializes in the development and manufacturing of small molecule active pharmaceutical ingredients (APIs), intermediates, and highly potent compounds. With a strong focus on innovation, it utilizes advanced technologies such as continuous flow manufacturing, biocatalysis, and its proprietary AJIPHASE and Corynex platforms. Headquartered in Belgium and operating as a subsidiary of the Ajinomoto Group, the company offers integrated solutions from preclinical stages through to commercial production. Its global footprint includes facilities in Europe, the United States, and Asia, supporting the production of complex molecules, peptides, oligonucleotides, and biologics.